DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $17.00 by Analysts at Stifel Nicolaus

Key Points

• Stifel Nicolaus has reduced its price target for DENTSPLY SIRONA from $19.00 to $17.00, maintaining a "hold" rating.
• Despite the downgrade, the new target suggests a potential upside of 33.39% from the stock's current trading price.
• DENTSPLY SIRONA reported earnings of $0.52 per share for the previous quarter, slightly surpassing analysts' expectations.

DENTSPLY SIRONA (NASDAQ:XRAY - Free Report) had its price objective reduced by Stifel Nicolaus from $19.00 to $17.00 in a research report released on Friday morning,Benzinga reports. They currently have a hold rating on the medical instruments supplier's stock.

A number of other analysts have also recently commented on the company. UBS Group dropped their price target on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Friday, May 9th. Wall Street Zen raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Sunday, July 13th. Morgan Stanley lowered shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a report on Tuesday, April 15th. Piper Sandler decreased their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a report on Wednesday, April 30th. Finally, Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a report on Monday, July 21st. Twelve analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat, DENTSPLY SIRONA has a consensus rating of "Hold" and a consensus price target of $18.64.

DENTSPLY SIRONA Stock Down 2.0%

DENTSPLY SIRONA stock traded down $0.27 during trading hours on Friday, hitting $12.96. 7,388,427 shares of the stock traded hands, compared to its average volume of 4,026,020. The firm's 50-day moving average price is $15.71 and its two-hundred day moving average price is $15.87. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. The company has a market cap of $2.59 billion, a PE ratio of -2.73, a PEG ratio of 0.80 and a beta of 0.94. DENTSPLY SIRONA has a one year low of $12.16 and a one year high of $27.48.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%. The firm had revenue of $936.00 million for the quarter, compared to analysts' expectations of $929.67 million. During the same period in the previous year, the firm posted $0.49 EPS. The business's revenue for the quarter was down 4.9% compared to the same quarter last year. On average, research analysts forecast that DENTSPLY SIRONA will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 4.9%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio is -14.10%.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently modified their holdings of XRAY. Cetera Investment Advisers increased its stake in DENTSPLY SIRONA by 27.5% in the 2nd quarter. Cetera Investment Advisers now owns 27,064 shares of the medical instruments supplier's stock worth $430,000 after buying an additional 5,839 shares in the last quarter. Creative Planning increased its stake in DENTSPLY SIRONA by 311.9% in the 2nd quarter. Creative Planning now owns 113,875 shares of the medical instruments supplier's stock worth $1,808,000 after buying an additional 86,227 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in DENTSPLY SIRONA by 7.8% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 51,204 shares of the medical instruments supplier's stock worth $813,000 after buying an additional 3,687 shares in the last quarter. Police & Firemen s Retirement System of New Jersey boosted its holdings in shares of DENTSPLY SIRONA by 4.3% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 75,526 shares of the medical instruments supplier's stock valued at $1,199,000 after purchasing an additional 3,104 shares during the last quarter. Finally, PNC Financial Services Group Inc. boosted its holdings in shares of DENTSPLY SIRONA by 88.8% during the 2nd quarter. PNC Financial Services Group Inc. now owns 29,342 shares of the medical instruments supplier's stock valued at $466,000 after purchasing an additional 13,797 shares during the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.